Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Andrology

  Free Subscription


Articles published in Prostate

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    July 2017
  1. COLINOT DL, Garbuz T, Bosland MC, Wang L, et al
    The common parasite Toxoplasma gondii induces prostatic inflammation and microglandular hyperplasia in a mouse model.
    Prostate. 2017;77:1066-1075.
    PubMed     Text format     Abstract available


    June 2017
  2. NA R, Helfand BT, Chen H, Conran CA, et al
    A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).
    Prostate. 2017 Jun 28. doi: 10.1002/pros.23380.
    PubMed     Text format     Abstract available


  3. PEJCIC T, Tosti T, Tesic Z, Milkovic B, et al
    Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.
    Prostate. 2017 Jun 8. doi: 10.1002/pros.23365.
    PubMed     Text format     Abstract available


  4. NYGARD LH, Talala K, Taari K, Tammela TLJ, et al
    The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasia.
    Prostate. 2017;77:1029-1035.
    PubMed     Text format     Abstract available


    May 2017
  5. MIZOGUCHI S, Mori K, Wang Z, Liu T, et al
    Effects of Estrogen Receptor beta Stimulation in a Rat Model of Non-Bacterial Prostatic Inflammation.
    Prostate. 2017;77:803-811.
    PubMed     Text format     Abstract available


  6. HENNENBERG M, Acevedo A, Wiemer N, Kan A, et al
    Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction is Sufficient to Replace alpha1 -Adrenergic Tension in the Human Prostate.
    Prostate. 2017;77:697-707.
    PubMed     Text format     Abstract available


  7. SHIBATA Y, Arai S, Miyazawa Y, Shuto T, et al
    Effects of Steroidal Antiandrogen or 5-alpha-reductase Inhibitor on Prostate Tissue Hormone Content.
    Prostate. 2017;77:672-680.
    PubMed     Text format     Abstract available


  8. HENRY G, Malewska A, Mauck R, Gahan J, et al
    Molecular pathogenesis of human prostate basal cell hyperplasia.
    Prostate. 2017;77:1344-1355.
    PubMed     Text format     Abstract available


  9. MILBRANDT M, Winter AC, Nevin RL, Pakpahan R, et al
    Insight into infection-mediated prostate damage: Contrasting patterns of C-reactive protein and prostate-specific antigen levels during infection.
    Prostate. 2017;77:1325-1334.
    PubMed     Text format     Abstract available


    April 2017
  10. GONCALVES BF, de Campos SG, Goes RM, Scarano WR, et al
    Dual action of high estradiol doses on MNU-induced prostate neoplasms in a rodent model with high serum testosterone: Protective effect and emergence of unstable epithelial microenvironment.
    Prostate. 2017 Apr 12. doi: 10.1002/pros.23353.
    PubMed     Text format     Abstract available


  11. SANCHEZ LR, Breser ML, Godoy GJ, Salazar FC, et al
    Chronic Infection of the Prostate by Chlamydia muridarum Is Accompanied by Local Inflammation and Pelvic Pain Development.
    Prostate. 2017;77:517-529.
    PubMed     Text format     Abstract available


    February 2017
  12. INAMURA S, Shinagawa T, Hoshino H, Sakai Y, et al
    Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.
    Prostate. 2017 Feb 9. doi: 10.1002/pros.23319.
    PubMed     Text format     Abstract available


  13. FUNAHASHI Y, Majima T, Matsukawa Y, Yamamoto T, et al
    Intraprostatic Reflux of Urine Induces Inflammation in a Rat.
    Prostate. 2017;77:164-172.
    PubMed     Text format     Abstract available


    January 2017
  14. BRESER ML, Motrich RD, Sanchez LR, Rivero VE, et al
    Chronic Pelvic Pain Development and Prostate Inflammation in Strains of Mice With Different Susceptibility to Experimental Autoimmune Prostatitis.
    Prostate. 2017;77:94-104.
    PubMed     Text format     Abstract available


    December 2016
  15. KLAASSEN Z, Howard LE, Moreira DM, Andriole GL Jr, et al
    Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.
    Prostate. 2016 Dec 19. doi: 10.1002/pros.23285.
    PubMed     Text format     Abstract available


  16. ZHOU Y, Copeland B, Otto-Duessel M, He M, et al
    Low Testosterone Alters the Activity of Mouse Prostate Stem Cells.
    Prostate. 2016 Dec 14. doi: 10.1002/pros.23290.
    PubMed     Text format     Abstract available


    November 2016
  17. WALLUKAT G, Jandrig B, Kunze R, Wendler JJ, et al
    Autoantibodies Directed Against the Endothelin A Receptor in Patients With Benign Prostatic Hyperplasia.
    Prostate. 2016 Nov 24. doi: 10.1002/pros.23284.
    PubMed     Text format     Abstract available


  18. REGIS L, Planas J, Carles J, Maldonado X, et al
    Free Testosterone During Androgen Deprivation Therapy Predicts Castration-Resistant Progression Better Than Total Testosterone.
    Prostate. 2016 Nov 1. doi: 10.1002/pros.23256.
    PubMed     Text format     Abstract available


    October 2016
  19. CAPOGROSSO P, Ventimiglia E, Moschini M, Boeri L, et al
    Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized Medicine.
    Prostate. 2016 Oct 24. doi: 10.1002/pros.23266.
    PubMed     Text format     Abstract available


    July 2016
  20. NAKATA D, Nakayama K, Masaki T, Tanaka A, et al
    Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.
    Prostate. 2016 Jul 30. doi: 10.1002/pros.23238.
    PubMed     Text format     Abstract available


  21. RUSSO GI, Cimino S, Castelli T, Favilla V, et al
    Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
    Prostate. 2016 Jul 25. doi: 10.1002/pros.23237.
    PubMed     Text format     Abstract available


  22. GU NY, Kim JH, Han IH, Im SJ, et al
    Trichomonas vaginalis induces IL-1beta production in a human prostate epithelial cell line by activating the NLRP3 inflammasome via reactive oxygen species and potassium ion efflux.
    Prostate. 2016;76:885-96.
    PubMed     Text format     Abstract available


    June 2016
  23. KIM JH, Kim SS, Han IH, Sim S, et al
    Proliferation of prostate stromal cell induced by benign prostatic hyperplasia epithelial cell stimulated with Trichomonas vaginalis via crosstalk with mast cell.
    Prostate. 2016 Jun 21. doi: 10.1002/pros.23227.
    PubMed     Text format     Abstract available


  24. GERRIN SJ, Sowalsky AG, Balk SP, Ye H, et al
    Mutation profiling indicates high grade prostatic intraepithelial neoplasia as distant precursors of adjacent invasive prostatic adenocarcinoma.
    Prostate. 2016 Jun 8. doi: 10.1002/pros.23212.
    PubMed     Text format     Abstract available


    April 2016
  25. AUSTIN DC, Strand DW, Love HL, Franco OE, et al
    NF-kappaB and androgen receptor variant expression correlate with human BPH progression.
    Prostate. 2016;76:491-511.
    PubMed     Text format     Abstract available


    March 2016
  26. CHA YJ, Lee JH, Han HH, Kim BG, et al
    MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
    Prostate. 2016 Mar 28. doi: 10.1002/pros.23183.
    PubMed     Text format     Abstract available


    February 2016
  27. NIRAULA S, Templeton AJ, Vera-Badillo FE, Joshua AM, et al
    Study of testosterone-guided androgen deprivation therapy in management of prostate cancer.
    Prostate. 2016;76:235-42.
    PubMed     Text format     Abstract available


    January 2016
  28. LEE SS, Yang YW, Tsai TH, Kuo YH, et al
    5-alpha-reductase inhibitors and the risk of diabetes mellitus: A nationwide population-based study.
    Prostate. 2016;76:41-7.
    PubMed     Text format     Abstract available


    November 2015
  29. HOLMSTROM F, Shimizu S, Shimizu T, Higashi Y, et al
    Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat.
    Prostate. 2015;75:1774-82.
    PubMed     Text format     Abstract available


    September 2015
  30. VITAL P, Castro P, Ittmann M
    Oxidative stress promotes benign prostatic hyperplasia.
    Prostate. 2015 Sep 29. doi: 10.1002/pros.23100.
    PubMed     Text format     Abstract available


  31. LIU Y, Zhao X, Sun X, Li Y, et al
    Expression of IL-17A, E, and F and their receptors in human prostatic cancer: Comparison with benign prostatic hyperplasia.
    Prostate. 2015 Sep 10. doi: 10.1002/pros.23058.
    PubMed     Text format     Abstract available


    August 2015
  32. LATIL A, Petrissans MT, Rouquet J, Robert G, et al
    Effects of hexanic extract of serenoa repens (permixon 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
    Prostate. 2015 Aug 26. doi: 10.1002/pros.23059.
    PubMed     Text format     Abstract available


    July 2015
  33. THOMAS LN, Merrimen J, Bell DG, Rendon R, et al
    Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
    Prostate. 2015 Jul 22. doi: 10.1002/pros.23054.
    PubMed     Text format     Abstract available


    June 2015
  34. NAKATA W, Nakai Y, Yoshida T, Sato M, et al
    Bone marrow-derived cells contribute to regeneration of injured prostate epithelium and stroma.
    Prostate. 2015;75:806-14.
    PubMed     Text format     Abstract available


    May 2015
  35. BERNICHTEIN S, Pigat N, Camparo P, Latil A, et al
    Anti-inflammatory properties of Lipidosterolic extract of Serenoa repens (Permixon(R)) in a mouse model of prostate hyperplasia.
    Prostate. 2015;75:706-22.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Andrology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: